RUTW241126C2005000
- 0.00
- 0.000.00%
Russell 2000 Index Newsroom
Trump Picks Scott Bessent as Treasury Secretary, What Does It Mean for the Financial Markets?
Axsome Therapeutics Reveals AXS-12 Meets Primary Endpoint In ENCORE Long-Term Phase 3 Trial In Narcolepsy
JetBlue Airways Analyst Ratings
Blue Bird Analyst Ratings
PAR Technology Analyst Ratings
MoneyLion Analyst Ratings
Roche Anti-TIGIT Therapy Fails to Extend Survival in Late-stage Lung Cancer Trial
Cassava Sciences Analyst Ratings
UBS Upgrades Hanesbrands to Buy, Raises Price Target to $11
Embecta Says For Fiscal Year 2025, Excluding The Patch Pump Program, Revenues Are Expected To Be $1.093B-$1.11B Vs. Consensus Of $1.12B, With Adjusted EPS Of $2.70-$2.90 Vs. Consensus Of $2.27
American Woodmark Misses Top-line and Bottom-line Estimates; Reaffirms FY25 Outlook
Embecta Beats Top-line and Bottom-line Estimates; Initiates FY25 Outlook
Embecta To Discontinue Insulin Patch Pump Program And Initiate An Organizational Restructuring Plan
Longbow Research Downgrades Summit Materials to Neutral
Rumble Stock Rises In Tuesday Pre-Market After Adopting Bitcoin Treasury Strategy As BTC Retreats
HC Wainwright & Co. Maintains Buy on Scholar Rock Holding, Raises Price Target to $50
First Interstate BancSys Analyst Ratings
William Blair Initiates Coverage On Cargo Therapeutics With Outperform Rating
MicroStrategy, Coinbase, And Other Bitcoin-Linked Stocks Tumble As BTC's March To $100,000 Stalls
Cargo Therapeutics Analyst Ratings